Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TRIM22 |
| Upstream (Parents) |
|---|
| (<<) GIMAP4 → TRIM22 |
| (<<) CYBB → TRIM22 |
| (<<) HCLS1 → TRIM22 |
| Downstream (Children) |
|---|
| TRIM22 → GBP1 (>>) |
| TRIM22 → BTN3A3 (>>) |
| TRIM22 → MAP7 (>>) |
| TRIM22 → NAIP (>>) |
| TRIM22 → IFI44L (>>) |
| TRIM22 → ITM2A (>>) |
| TRIM22 → KLRD1 (>>) |
| TRIM22 → ENPP2 (>>) |
| TRIM22 → GZMA (>>) |
| TRIM22 → BST2 (>>) |
| TRIM22 → IFI6 (>>) |
| TRIM22 → IFI44 (>>) |
| TRIM22 → IL2RB (>>) |
| TRIM22 → OAS2 (>>) |
| TRIM22 → APOBEC3G (>>) |
| TRIM22 → CCDC64 (>>) |
| TRIM22 → TNFAIP2 (>>) |
| TRIM22 → UBE2L6 (>>) |
